Official Title
Evaluation of a COVID-19 Screening Strategy Combining Chest Low Dose CT and RT-PCR Test for Patients Admitted for Surgical or Interventional Procedures During the COVID 19 Outbreak
Brief Summary

This research aims to improve the screening for COVID-19 upon admission to the Montpellier University Hospital for an act under general anesthesia or at high risk of transmission of the virus. Indeed, routine nasal swabs present many false negatives (60 to 70%) and many patients with the coronavirus have little or no symptoms. Performing a chest CT scan can reveal early signs very suggestive of viral pneumoniae due to the new coronavirus without additional risk compared to a simple chest X-ray (no injection of contrast medium, low exposure). The objective is to assess the sensitivity of the diagnosis of COVID-19 by carrying out a nasopharyngeal RT-PCR and a low dose thoracic scanography at the hospital admission of patients scheduled to a procedure under general anesthesia or at risk of aerosolization (surgery, endoscopy, procedures involving risk of interventional radiology) in order to limit the risks of transmission to healthcare professionals or other patients and to rationalize the use of protective equipment. This is an observational research without modification of care in the setting of COVID-19 pandemia. All clinical and biological data will be issued from routine care and medical charts. Routine use of CT scan and nasal swabs is an institutional approved strategy. Serologic tests will be performed as soon as available from serum collection collected after routine blood analysis. All data will be anonymously recorded after information and non-opposition of the patient.

Completed
COVID 19
SARS-CoV-2
Eligibility Criteria

Inclusion criteria:

- Scheduled or unscheduled surgical or interventional procedure with at least one night
in hospital

- Chest CT-scan within the first 24 hours

- Nasopharyngeal swaps within 24 hours before or after hospital admission

Exclusion criteria :

- Age under 18 years

- Patient with restriction of freedom

- Vital surgical emergency

- Direct admission to the COVID dedicated hospital

- Opposition to data utilization

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 99 Years
Countries
France
Locations

Uh Montpellier
Montpellier, France

Philippe Gaudard, MD, Principal Investigator
University Hospital, Montpellier

University Hospital, Montpellier
NCT Number
Keywords
COVID-19 infection or paucy-symptomatic carriage
In-hospital screening
Chest CT-scan
MeSH Terms
COVID-19